Cadila Pharms Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CADILA PHARMS LTD
CADILA PHARMS LTD has thirty-one approved drugs.
Summary for Cadila Pharms Ltd
| US Patents: | 0 |
| Tradenames: | 29 |
| Ingredients: | 29 |
| NDAs: | 31 |
Drugs and US Patents for Cadila Pharms Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cadila Pharms Ltd | OLANZAPINE | olanzapine | TABLET;ORAL | 210022-004 | Feb 24, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Cadila Pharms Ltd | ACYCLOVIR | acyclovir | TABLET;ORAL | 202168-002 | Nov 15, 2013 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Cadila Pharms Ltd | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET;ORAL | 206250-005 | Nov 21, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Cadila Pharms Ltd | PREGABALIN | pregabalin | CAPSULE;ORAL | 206452-002 | Jul 12, 2023 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
